FDA Pushes to Reduce Single-Source Generics, Increase Biosimilars

By Ed Lamb, DrugPatentWatch writer Under a new commissioner dedicated to bolstering competition to reduce prices, the agency is redoing a raft of rules and guidances to speed ANDA approvals…

The post FDA Pushes to Reduce Single-Source Generics, Increase Biosimilars appeared first on DrugPatentWatch.


Comments are closed.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog